BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Epocal Inc. Receives FDA Approval To Market The EPOCTM Blood Analysis System


10/12/2006 9:06:26 AM

OTTAWA, Oct. 11 /PRNewswire/ - Epocal is pleased to announce receipt of 510(k) clearance from the US Food and Drug Administration to market its first product - the EPOCTM Enterprise Point of Care Blood Analysis System - in the United States.

The EPOC system is a blood analyzer that rapidly performs a panel of the most critical acute care tests at the patient bedside. The product features smart-card-like diagnostic test cards and a portable PDA analyzer with wireless connectivity to the hospital information system.

"We will now commence the commercialization phase of the Company's first product," announced Imants Lauks, Epocal Chief Executive Officer. "As is typical for new technology entrants into the market, we will begin with a controlled launch of our product in the United States in the first quarter of 2007, followed by broader commercialization later in the year."

Dr. James H. Nichols, Director of Clinical Chemistry at Baystate Medical Center, a 700-bed hospital in Massachusetts, has performed clinical evaluations of the EPOC system and had the following comments, "This is the first handheld wireless blood gas and electrolyte analyzer to be introduced into the point of care testing market. With technical performance comparable to blood gas analyzers currently on the market, it will certainly be competitive given its advantages of handheld portability and wireless data connectivity."

Kelly Holman, Managing Director of Genesys Capital Partners of Toronto, Canada, added, "This event is another key milestone for the company as it continues to build value. We look forward to continuing our support of the company on its mission to transform the delivery of patient care at the bedside."

Epocal Inc.

CONTACT: Joyce Wilson, (613) 738-6192, ext.: 224; the company atinfo@epocal.com, or visit the company web site www.epocal.com

>>> Discuss This Story



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES